The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
search results
LIMIT by DATE
From:
To:

Save Search

HELP and INFORMATION
- Search Help
- Saved NEJM Searches
       

 

Viewing 1-20 of 1036722 Medline results for thisweek.asp;29
Result Page: < Previous 1 2 3 4 5 of 51837 Next >
Phage phi29 protein p56 prevents viral DNA replication impairment caused by uracil excision activity of uracil-DNA glycosylase.
G Serrano-Heras, A Bravo, and M Salas
PNAS, Dec 2008; 105: 19044-9. Journal article
Abstract  |  Full text  

Caenorhabditis elegans levamisole resistance genes lev-1, unc-29, and unc-38 encode functional nicotinic acetylcholine receptor subunits.
JT Fleming, MD Squire, TM Barnes, C Tornoe, K Matsuda, J Ahnn, A Fire, JE Sulston, EA Barnard, DB Sattelle, and JA Lewis
J. Neurosci., Aug 1997; 17: 5843-57. Journal article
Abstract  |  Full text  

MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.
H Xu, IY Cheung, HF Guo, and NK Cheung
Cancer Res, Aug 2009; 69: 6275-81. Journal article
Abstract  

Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use.
FA van der Linden, JJ Kragt, M Klein, HM van der Ploeg, CH Polman, and BM Uitdehaag
J. Neurol. Neurosurg. Psychiatry, Dec 2005; 76: 1677-81. Journal article
Abstract  |  Full text  

IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression.
S Brand, F Beigel, T Olszak, K Zitzmann, ST Eichhorst, JM Otte, J Diebold, H Diepolder, B Adler, CJ Auernhammer, B Goke, and J Dambacher
Am J Physiol Gastrointest Liver Physiol, Nov 2005; 289: G960-8. Journal article
Abstract  |  Full text  

The multiple sclerosis impact scale (MSIS-29) is a reliable and sensitive measure.
C McGuigan and M Hutchinson
J. Neurol. Neurosurg. Psychiatry, Feb 2004; 75: 266-9. Journal article
Abstract  |  Full text  

Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock.
A Giacometti, O Cirioni, R Ghiselli, F Mocchegiani, G D'Amato, R Circo, F Orlando, B Skerlavaj, C Silvestri, V Saba, M Zanetti, and G Scalise
Am. J. Respir. Crit. Care Med., Jan 2004; 169: 187-94. In vitro
Abstract  |  Full text  

The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.
J Hobart, D Lamping, R Fitzpatrick, A Riazi, and A Thompson
Brain, May 2001; 124: 962-73. Journal article
Abstract  |  Full text  

Cloning, expression, and protective immunity in mice of a gene encoding the diagnostic antigen P-29 of Echinococcus granulosus.
Z Shi, Y Wang, Z Li, Z Li, Y Bo, R Ma, and W Zhao
Acta Biochim Biophys Sin, Jan 2009; 41: 79-85. Journal article
Abstract  |  Full text  

99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection.
MS Akhtar, J Iqbal, MA Khan, J Irfanullah, M Jehangir, B Khan, I Ul-Haq, G Muhammad, MA Nadeem, MS Afzal, and MB Imran
J. Nucl. Med., May 2004; 45: 849-56. Journal article
Abstract  |  Full text  

Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples.
A Riazi, JC Hobart, DL Lamping, R Fitzpatrick, and AJ Thompson
J. Neurol. Neurosurg. Psychiatry, Dec 2002; 73: 701-4. Evaluation studies
Abstract  |  Full text  

Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
O Gray, G McDonnell, and S Hawkins
Multiple Sclerosis, Jan 2009; 15: 75-80. Journal article
Abstract  

High energy shock waves (HESW) for sonodynamic therapy: effects on HT-29 human colon cancer cells.
R Canaparo, L Serpe, MG Catalano, O Bosco, GP Zara, L Berta, and R Frairia
Anticancer Res, Sep 2006; 26: 3337-42. Journal article
Abstract  

Human fecal water inhibits COX-2 in colonic HT-29 cells: role of phenolic compounds.
PC Karlsson, U Huss, A Jenner, B Halliwell, L Bohlin, and JJ Rafter
J. Nutr., Oct 2005; 135: 2343-9. Journal article
Abstract  |  Full text  

Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.
EL Hoogervorst, JN Zwemmer, B Jelles, CH Polman, and BM Uitdehaag
Multiple Sclerosis, Oct 2004; 10: 569-74. Journal article
Abstract  

Functional interactions between a phage histone-like protein and a transcriptional factor in regulation of phi29 early-late transcriptional switch.
M Elias-Arnanz and M Salas
Genes & Dev., Oct 1999; 13: 2502-13. Journal article
Abstract  |  Full text  

Docosahexaenoic acid accumulates in cardiolipin and enhances HT-29 cell oxidant production.
SM Watkins, LC Carter, and JB German
J. Lipid Res., Aug 1998; 39: 1583-8. Journal article
Abstract  |  Full text  

Listeriolysin O affects barrier function and induces chloride secretion in HT-29/B6 colon epithelial cells.
JF Richter, AH Gitter, D Gunzel, S Weiss, W Mohamed, T Chakraborty, M Fromm, and JD Schulzke
Am J Physiol Gastrointest Liver Physiol, Jun 2009; 296: G1350-9. Journal article
Abstract  |  Full text  

Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.
Y Pekarsky, U Santanam, A Cimmino, A Palamarchuk, A Efanov, V Maximov, S Volinia, H Alder, CG Liu, L Rassenti, GA Calin, JP Hagan, T Kipps, and CM Croce
Cancer Res., Dec 2006; 66: 11590-3. Journal article
Abstract  |  Full text  

Caspase-3 activation and induction of PARP cleavage by cyclic dipeptide cyclo(Phe-Pro) in HT-29 cells.
SC Brauns, G Dealtry, P Milne, R Naude, and M Van de Venter
Anticancer Res, Nov 2005; 25: 4197-202. Journal article
Abstract  


Result Page: < Previous 1 2 3 4 5 of 51837 Next >
Advertisement



 


Advertisement



 


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.